Testing an early online intervention for the treatment of disturbed sleep during the COVID-19 pandemic (Sleep COVID-19): structured summary of a study protocol for a randomised controlled trial by Elder, Greg J. et al.
Northumbria Research Link
Citation: Elder, Greg J., Alfonso-Miller, Pamela, Atkinson, William, Santhi, Nayantara and Ellis, Jason 
(2020) Testing an early online intervention for the treatment of disturbed sleep during the COVID-19 
pandemic (Sleep COVID-19): structured summary of a study protocol for a randomised controlled trial. 
Trials, 21 (1). p. 704. ISSN 1745-6215 
Published by: BioMed Central
URL: https://doi.org/10.1186/s13063-020-04644-0 <https://doi.org/10.1186/s13063-020-04644-0>
This  version  was  downloaded  from  Northumbria  Research  Link: 
http://nrl.northumbria.ac.uk/id/eprint/45035/
Northumbria University has developed Northumbria Research Link (NRL) to enable users to access 
the University’s research output. Copyright © and moral rights for items on NRL are retained by the 
individual author(s) and/or other copyright owners.  Single copies of full items can be reproduced, 
displayed or performed, and given to third parties in any format or medium for personal research or 
study, educational, or not-for-profit purposes without prior permission or charge, provided the authors, 
title and full bibliographic details are given, as well as a hyperlink and/or URL to the original metadata 
page. The content must not be changed in any way. Full items must not be sold commercially in any  
format or medium without formal permission of the copyright holder.  The full policy is available online: 
http://nrl.northumbria.ac.uk/pol  i cies.html  
This  document  may differ  from the  final,  published version of  the research  and has been made 
available online in accordance with publisher policies. To read and/or cite from the published version 
of the research, please visit the publisher’s website (a subscription may be required.)
                        

Elder et al. Trials          (2020) 21:704 
https://doi.org/10.1186/s13063-020-04644-0LETTER Open AccessTesting an early online intervention for the
treatment of disturbed sleep during the
COVID-19 pandemic (Sleep COVID-19):
structured summary of a study protocol for
a randomised controlled trial
Greg J. Elder*, Pamela Alfonso-Miller, William C. M. Atkinson, Nayantara Santhi and Jason G. EllisAbstract
Objectives: The primary aim of the present study is to examine the efficacy of an online intervention for poor
sleep in the context of an ongoing stressful major life event, by assessing if this intervention can reduce insomnia
severity at short-term (one week post-intervention) and long-term (one and three months post-intervention) follow-
up time points. It is hypothesised that the intervention will: 1) reduce insomnia severity in poor sleepers, compared
to wait-list control poor sleepers, and good sleepers; 2) reduce subjective symptoms of anxiety and depression in
all groups, and 3) prevent the transition to acute insomnia in good sleepers.
Trial design: This study is a cluster randomised controlled trial.
Participants: Both healthy good sleepers, who do not report having any current sleep problems, and individuals
who report having sleep problems, will be recruited for the present study. This is a single-site study (Northumbria
University). This study will be delivered using the internet and there are no geographic restrictions. Individuals who
self-report as poor sleepers will meet DSM-5 criteria for acute insomnia, which is where individuals: 1) have
difficulties in falling asleep, staying asleep, or awakening too early for at least three nights per week, for a time
period of between two weeks and three months; and 2) report experiencing distress or impairment caused by
sleep loss. Both 1) and 2) must have occurred despite the individual having had an adequate opportunity for sleep
during this time period. Good sleepers will be individuals who do not have current sleep problems. All participants
must have a sufficient level of English comprehension to understand and complete study measures. Individuals
cannot participate if they report having chronic sleep problems (where they have existed for more than three
months immediately prior to providing consent), nor will individuals who are actively seeking treatment for their
sleep problems irrespective of how long they have had the sleep problem. Individuals also cannot participate if
they have a self-reported history of head injuries, or if they have a self-reported diagnosis of schizophrenia, epilepsy
or personality disorder, as the distraction techniques involved in the insomnia intervention may increase rumination
in individuals with these conditions, and influence the effectiveness of the intervention.
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Intervention and comparator: Participants who receive the intervention will be provided with an online version
of a self-help leaflet. A printed version of this leaflet has been successfully used in previous treatment studies, which
have been conducted by our research group. Participants will be encouraged to download, save or print out this
leaflet, which will be provided in PDF format. There will be no restrictions on use and participants will be
encouraged to refer to this leaflet as often as they wish to. Briefly, this self-help leaflet aims to improve sleep by
identifying and addressing sleep-related dysfunctional thinking by providing education about sleep, providing
techniques to distract from intrusive worrisome thoughts at night, and providing guidelines for sleep-related
stimulus control. The comparator is a wait-list control (i.e. where they will receive the intervention after a one
month delay) group.
Main outcomes: The primary outcome measure will be insomnia severity, as measured using the Insomnia Severity
Index (Bastien, Vallières, & Morin, 2001), assessed immediately prior to the intervention and at one week, one month
and three months post-intervention, compared to baseline. Secondary outcome measures will include subjective
mood, measured using the 7-item Generalised Anxiety Disorder Questionnaire (GAD-7; Spitzer, Kroenke, Williams, &
Lowe, 2006)) and 9-item Patient Health Questionnaire (PHQ-9; Kroenke, Spitzer, & Williams, 2001), assessed
immediately prior to the intervention, and one week, one month and three months post-intervention, compared to
baseline. Additionally, subjective sleep continuity, derived from sleep diaries (Carney et al., 2012), will be compared
pre and post-intervention.
Randomisation: This study will operate as a cluster randomised controlled trial. Good sleepers will be randomised
into an intervention or a no-intervention group, with a 1:1 allocation. Poor sleepers will be randomised into an
intervention or wait-list control group, with a 1:1 allocation. Randomisation will be conducted automatically using
Qualtrics study software, where block sizes will be equal and randomisation will be computer-generated.
Blinding (masking): Participants will not be blinded to group assignment. The outcomes will be assessed by a
blinded investigator.
Numbers to be randomised (sample size): The minimum sample size is 60. A total of 30 poor sleepers will be
randomised to the intervention or wait-list control group. A total of 30 good sleepers will be randomised to the
intervention or no intervention group.
Trial Status: Recruitment for this study has yet to start. It is anticipated that recruitment will begin in August 2020
and end in April 2022. The current study protocol is version 1.0 (20 July 2020)
Trial registration: This study was prospectively registered in the ISRCTN registry (registration number ISRCTN43
900695, date of registration: 8 April 2020).
Full protocol: The full protocol is attached as an additional file, accessible from the Trials website (Additional file 1).
In the interest in expediting dissemination of this material, the familiar formatting has been eliminated; this Letter
serves as a summary of the key elements of the full protocol.
The study protocol has been reported in accordance with the Standard Protocol Items: Recommendations for
Clinical Interventional Trials (SPIRIT) guidelines (Additional file 2).
Keywords: COVID-19, Randomised controlled trial, protocol, SARS-COV-2, acute insomnia, brief intervention, online
intervention, CBT-I, short-term insomnia
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Additional file 1. Study protocol (v1.0, 20 July 2020).
Additional file 2. SPIRIT 2013 Checklist: Recommended items to address
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